Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Fentanyl
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 46, 70, 97, 231, 298 💬
2Fentanyl (LOW dose) + dexmedetomidine
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 215 💬
3Fentanyl B. braun
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 97 💬
4Fentanyl transdermal patch
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 46 💬
5Transdermal fentanyl matrix, gabapentin
(D10811)		----[1] 70 💬